.jpg | CAS_number = 56124-62-0 | ATC_prefix = L01 | ATC_suffix = DB09 | ATC_supplemental = | PubChem = 41744 | DrugBank = APRD00662 | chemical_formula = C₃₄H₃₆F₃NO₁₃ | molecular_weight = 723.644 g/mol | bioavailability = | protein_bound = >99% | metabolism = | elimination_half-life = | pregnancy_category = | legal_status = | routes_of_administration = }} Valrubicin (N-trifluoroacetyladriamycin-14-valerate, Valstar®) is a chemotherapy drug used to treat bladder cancer. Valrubicin is a semisynthetic analog of the anthracycline doxorubicin, and is administered by infusion directly into the bladder.

Dosage

---

800 mg weekly for 6 weeks

Side effects

---

• Blood in urine
• Incontinence
• painful or difficult urination
• Unusually frequent urination

More on [ Valrubicin ]

Subscribe to Valrubicin RSS feed